Procter & Gamble finally shows movement this week — but it is the short book retreating and a cluster of senior insider sales arriving simultaneously that makes the setup worth examining.
Short interest dropped sharply, falling roughly 10% in a single session on August 25 to 1.05% of the free float, after holding stubbornly near 1.17% for the two weeks prior. That reverses the plateau flagged in last week's note, when the post-earnings short build had stalled rather than extended. The direction of travel has now clearly shifted: shorts that piled in around the August 11 burst are covering, not adding. Borrow conditions were never the constraint — availability is essentially unlimited, with nearly two billion shares available to lend against roughly 24 million shorted — so the covering reflects a change in conviction rather than a forced unwind. Cost to borrow remains trivial at 0.32%, down 16% on the week. The short score has eased from 31.1 to 30.1 over the past ten days, confirming the gradual pressure release. There is no squeeze mechanics at work here; this looks like discretionary covering ahead of the next hard catalyst.
Options positioning tells a calmer story than recent weeks. The put/call ratio is running at 0.67, fractionally below its 20-day average of 0.68 and near the lower end of the past year's range — the 52-week low is 0.59. That is mildly more call-tilted than usual, though the z-score of negative 0.27 means the deviation is statistically modest. Taken together with the short covering, positioning looks notably less defensive than it did entering the July 29 earnings print.
The week's standout, however, is the insider activity. A coordinated cluster of senior executive sales hit on August 20: the Chairman and CEO Jejurikar sold $888,000 worth of stock, CFO Schulten sold $777,000, Chief Brand Officer Pritchard sold $579,000, and the Chief Legal Officer sold $322,000 — all at $143.79. A further small sale from the Chief Accounting Officer followed on August 24. These are not trivial amounts, and the simultaneous filing across multiple C-suite roles on the same day at the same price is notable. The 90-day net insider position is a net sale of roughly $6.25 million. That said, the trade significance scores assigned are uniformly low (1-3 out of 10), suggesting the trades may reflect pre-scheduled plans rather than discretionary conviction, and the percentage of company affected in each case is tiny. Read them as a data point, not a signal.
On the Street, the direction of analyst travel has been mostly downward since the earnings miss. HSBC downgraded to Hold and cut its target from $182 to $149 on July 30, the same day Citi trimmed its Buy target from $181 to $170. Argus followed with a downgrade to Hold on August 7. JP Morgan and Bank of America both maintained positive ratings but reduced targets — JPM to $162, BofA to $166. The mean target is now $160.61, implying roughly 10% upside from the current $145.40, but the drift in target prices is clearly lower. The bull case rests on market share recovery and improving trends in Europe and Latin America; the bear case centres on SK-II's 30% sales decline in Greater China and softening US category growth. The forward earnings yield factor ranks at the 87th percentile for one-year EPS growth expectations, while the dividend score ranks at the 98th percentile — reminders that the income case for owning P&G remains structurally intact even as the growth narrative stalls. The PE multiple is sitting at 19.9x and drifting lower, down 0.75 turns over the past 30 days.
Among peers, Church & Dwight and Kimberly-Clark each gained around 3% on the week, meaningfully outpacing P&G's 1.4% gain. Colgate-Palmolive was essentially flat on the week. The pattern of P&G lagging its closest staples peers — flagged in recent notes — continues. The stock is up $0.72 from last week's close of $144.68, a fractional move that has not closed any of the gap to the pre-earnings $151-plus level.
The October 16 earnings date is now the organising event. Between now and then, what to watch is whether the short covering sustains or whether new shorts re-enter if the stock stalls again at current levels — and whether analyst targets continue their slow drift toward the current price.
See the live data behind this article on ORTEX.
Open PG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
